TBI MR Study 3 Houston Methodist

计划入组 16 人 · 首次发布于 2014 年 8 月 18 日

DeBakey Cardiovascular Magnetic Resonance Study

计划入组 100,000 人 · 首次发布于 2020 年 2 月 24 日

A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center

计划入组 500 人 · 首次发布于 2023 年 10 月 23 日

BAdv85C5

DKK1-A2 mAb(Houston Methodist Hospital)

Targeted S100A4/TfR bispecific antibody(Houston Methodist)

Houston Methodist Research Institute

United States

METHODIST REHABILITATION CENTER

United States

TMH Physician Organization

United States

Phase 3 DESTINY-Breast05 Trial Compares Trastuzumab Deruxtecan to T-DM1 in High-Risk HER2+ Early Breast Cancer

JANX007 Demonstrates Promising Efficacy and Manageable Safety Profile in Phase 1 Metastatic Prostate Cancer Trial

Houston Methodist Receives $110 Million Donation, Largest in Health System's 107-Year History